Clark Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Clark Asset Management's BMY Position: Q2 2026 in Review
Clark Asset Management increased its Bristol-Myers Squibb (BMY) stake by 9% in Q2 2026, buying an estimated $17.7K and bringing the position to 3,726 shares worth $215K. The position accounts for 0.02% of the portfolio, ranked #282.
Clark Asset Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 812 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Clark Asset Management held 3,726 shares of Bristol-Myers Squibb worth $215K as of Q2 2026.
- Clark Asset Management bought 309 Bristol-Myers Squibb shares in Q2 2026, an estimated $17.7K.
- Bristol-Myers Squibb made up 0.02% of Clark Asset Management's portfolio in Q2 2026, its #282 holding.
- Clark Asset Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 812 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Clark Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.